A Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine

Name: A Phase 3 Study to Evaluate the Immunogenicity and Safety of Minhai's PCV13-DT/TT Vaccine As Compared to Pfizer's PCV13 Vaccine
License: Public Domain

Beijing Minhai Biotechnology Co., Ltd

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

pneumococcal vaccines, pneumococcal infections

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 329579
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.